(Q39690576)

English

Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway

scientific article published on August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway (English)

1 reference

Europe PubMed Central

14 September 2017

1 reference

based on heuristic

inferred from title

endometrial carcinoma

1 reference

based on heuristic

inferred from title

author name string

Zhihong Ai

1

1 reference

Europe PubMed Central

14 September 2017

Juan Wang

2

1 reference

Europe PubMed Central

14 September 2017

Yudong Wang

3

1 reference

Europe PubMed Central

14 September 2017

Lihua Lu

4

1 reference

Europe PubMed Central

14 September 2017

Jianqian Tong

5

1 reference

Europe PubMed Central

14 September 2017

Yincheng Teng

6

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

1 August 2010

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

116

1 reference

Europe PubMed Central

14 September 2017

15

1 reference

Europe PubMed Central

14 September 2017

3603-3613

1 reference

Europe PubMed Central

14 September 2017

Novel molecular profiles of endometrial cancer-new light through old windows.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Endocrine therapy of endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of fertility-preserving treatment in young women with endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of steroid hormone receptors concentration in patients with endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR and cancer prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Difference in progesterone-receptor isoforms ratio between early and late first-trimester human trophoblast is associated with differential cell invasion and matrix metalloproteinase 2 expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor expression in three different human endometrial cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

The racial disparity in outcomes in endometrial cancer: could this be explained on a molecular level?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential expression of the A and B isoforms of progesterone receptor in human endometrial cancer cells. Only progesterone receptor B is induced by estrogen and associated with strong transcriptional activation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25220

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25220

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39690576&oldid=1856472545"